GPX4 and small cell lung carcinoma: Indeed, neoplastic types with limited therapeutic options such as small-cell lung cancer (SCLC) and triple-negative breast cancer (TNBC) exhibit susceptibility to ferroptosis due to their inherent distinctive metabolic characteristics, including increased intracellular levels of PUFA and LIP coupled with a reduced activity of the GPX4–GSH defense system [140,192].